System and methods for performing saliva-based diagnostic screenings
US-2024420847-A1 · Dec 19, 2024 · US
Ovulation predictor test
US8927262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8927262-B2 |
| Application number | US-89721610-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 4, 2010 |
| Priority date | Oct 4, 2010 |
| Publication date | Jan 6, 2015 |
| Grant date | Jan 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention is related to a diagnostic test kit for detecting luteinizing hormone (LH) in a biological sample at a concentration relative to a threshold concentration of LH. The device can include a release medium formed of a first material and including a labeled conjugate with a detectable label and a first binding member reactive with a first epitope of LH and a capture medium formed of a second, different material, in fluid communication with the release medium. The capture medium includes a result site having immobilized thereon a capture component capable of directly or indirectly binding LH that is bound to the labeled conjugate. The device is calibrated such that color development at the result site occurs only when the LH concentration of the liquid sample is greater than the threshold concentration.
First claim
Opening claim text (preview).
We claim: 1. A device for detecting the presence of an analyte in a biological sample comprising: a. a release medium formed of a first material, wherein said release medium is configured to receive the biological sample; b. a capture medium located downstream from said release medium and in fluid communication with said release medium; c. a result site located on said capture medium; d. a scavenger binding member located on one of said release medium and said capture medium…
Assignees
Inventors
Classifications
- G01N33/54388Primary
Physics · mapped topic
- G01N33/54386Primary
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8927262B2 cover?
- The present invention is related to a diagnostic test kit for detecting luteinizing hormone (LH) in a biological sample at a concentration relative to a threshold concentration of LH. The device can include a release medium formed of a first material and including a labeled conjugate with a detectable label and a first binding member reactive with a first epitope of LH and a capture medium form…
- Who is the assignee on this patent?
- Nazareth Albert R, Snowden Timothy, Boyle Mary Beth, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification G01N33/54388. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).